United States News All stories

Lindblad Expeditions Holdings (NASDAQ:LIND) acquired a 60% stake in White Desert and Echo Charlie for approximately $61 million, adding an Antarctic luxury travel operator and aviation-focused travel brand to its portfolio.

Innovative Industrial Properties (NYSE:IIPR) declared a third-quarter 2026 dividend of $1.90 per share of common stock, representing an annualized dividend of $7.60 per share.

CareTrust REIT (NYSE:CTRE) acquired a portfolio of skilled nursing facilities in the southwest for $400 million, adding 2,622 licensed beds to its healthcare real estate portfolio.

Eli Lilly (NYSE:LLY) will present new clinical trial data on retatrutide, Foundayo (orforglipron), and eloraTZP at the European Association for the Study of Diabetes 2026 meeting in Milan from September 28 to October 2.

Ducommun (NYSE:DCO) received a follow-on agreement valued at more than $35 million from Simmonds Precision Products to provide electronic assemblies for Lockheed Martin’s PAC-3 missile family.

Forgent Power Solutions (NYSE:FPS) reported fiscal fourth-quarter revenue of $462 million, up 94% year-over-year, with bookings of $1.503 billion and backlog reaching $3 billion for the period ended June 30, 2026.

Genworth Financial (NYSE:GNW) responded to a UK Court of Appeal ruling involving AXA’s claim against Santander companies related to historic Payment Protection Insurance mis-selling liabilities.

Strawberry Fields REIT (NYSE:STRW) completed the acquisition of a healthcare campus in Marshall, Missouri, adding a 60-bed hospital, a 99-bed skilled nursing facility, and a medical office building to its portfolio.

Transocean (NYSE:RIG) secured a two-well ultra-deepwater drilling contract for the Deepwater Conqueror in Equatorial Guinea, adding an estimated $80 million to the company’s backlog.

Rocket Lab (NASDAQ:RKLB) completed financing for its pending acquisition of Iridium Communications by raising $1.944 billion through an at-the-market equity program and amending Iridium’s existing term loan facility.

X-energy (NASDAQ:XE) and Centrica announced that the UK regulator accepted the Xe-100 advanced small modular reactor into the Generic Design Assessment process, moving the technology closer to potential UK commercial licensing.

Summit Therapeutics (NASDAQ:SMMT) reported updated overall survival results from the global Phase III HARMONi clinical trial showing ivonescimab plus chemotherapy continued to demonstrate survival results in patients with EGFR-mutated advanced non-small cell lung cancer.

Allarity Therapeutics (NASDAQ:ALLR) received a Japanese patent for its stenoparib-specific DRP companion diagnostic, covering methods to identify patients likely to benefit from stenoparib treatment.

Oil prices rose on Tuesday as supply concerns increased after attacks on Saudi Arabian energy infrastructure disrupted the East-West pipeline, with Brent crude futures gaining 1.77% to $107.55 a barrel and West Texas Intermediate (WTI) futures rising 1.85% to $103.27 a barrel.

Sempra Infrastructure (NYSE:SRE) signed a 20-year sales and purchase agreement with Petrobras for approximately 0.8 million tonnes per annum of liquefied natural gas from the Port Arthur LNG Phase 2 project in Texas.

Corteva (NYSE:CTVA) rejected efforts by several State Attorneys General to stop its planned separation, stating that the legal challenge is based on speculative PFAS liability claims.

Moody’s Corporation (NYSE:MCO) agreed to acquire a minority stake in Philippine Rating Services Corporation (PhilRatings), a domestic credit rating agency supporting the development of the Philippine debt capital markets.

Borr Drilling (NYSE:BORR) has entered agreements to divest its 51% equity stake in Mexican joint ventures Perfomex to its local partner, with completion expected in September 2026.

Abbott (NYSE:ABT) agreed to pay $385 million on September 14, 2026, to resolve government and civil claims connected to its 2022 powdered infant formula recall.

Oracle (NYSE:ORCL) disclosed that it is expanding its 2026 Restructuring Plan by approximately $700 million, bringing the estimated total cost of the program to roughly $2.8 billion.

Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to sell its DePuy Synthes orthopedics business to Apollo Global Management for approximately $20 billion.

Biofrontera (NASDAQ:BFRI) received U.S. FDA approval of a supplemental New Drug Application for its Ameluz 10% topical gel and BF-RhodoLED lamp to treat adult patients with superficial basal cell carcinoma.

707 Cayman Holdings (NASDAQ:JEM) announced it will not proceed with its previously proposed acquisition of Crucial Innovation following a board review.

Immersion Corporation (NASDAQ:IMMR) reported total revenues of $294.4 million for the first quarter of fiscal 2027, reversing a prior-year net loss.